A research team at the University of Wisconsin-Madison produced high-resolution images of RSV structure, important for RSV ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

Respiratory syncytial virus and influenza activity are on the rise in parts of the country, particularly among young children, according to the CDC's latest respiratory virus updates. Overall, the ...

Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...

It’s called respiratory syncytial virus (RSV), and while it’s usually not super serious in older kids and healthy young adults, it can be really risky for babies and older people. According to ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

New guidelines and the timing of COVID vaccinations impacted uptake of Abrysvo this year, according to a company executive.

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of ...